Lecap Asset Management Ltd. Grows Position in IQVIA Holdings Inc. (NYSE:IQV)
Lecap Asset Management Ltd. increased its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 411.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,738 shares of the medical research company’s stock after acquiring an additional 9,443 shares during the quarter. […]
Merck & Co., Inc. (NYSE:MRK) Shares Bought by RBA Wealth Management LLC
RBA Wealth Management LLC increased its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,097 shares of the company’s stock after buying an additional 1,045 shares during the period. […]
The Trade Desk, Inc. (NASDAQ:TTD) Shares Sold by Mattern Wealth Management LLC
Mattern Wealth Management LLC trimmed its stake in shares of The Trade Desk, Inc. (NASDAQ:TTD – Free Report) by 5.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,320 shares of the technology company’s stock after selling 250 shares during the quarter. Mattern […]
Gilead Sciences, Inc. (NASDAQ:GILD) Position Boosted by Bellecapital International Ltd.
Bellecapital International Ltd. lifted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 56.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,705 shares of the biopharmaceutical company’s stock after purchasing an additional 6,750 shares during the period. Bellecapital International […]
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Krane Funds Advisors LLC
Krane Funds Advisors LLC raised its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,107 shares of the biopharmaceutical company’s stock after purchasing an additional 182 shares during the […]
last updated on 23 Oct 16:22